Company intelligence / Profile preview

Conduit Pharmaceuticals Inc.

Naples, Florida, United Statesconduitpharma.com ↗
Ownership
Public · CDT
Employees
~6
Development stage
Phase 2
01

Overview

Conduit has completed Phase I trials for AZD1656 in type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor. AZD5904 has completed Phase I trials for idiopathic male infertility. The company is currently designing a Phase IIa clinical trial for AZD1656 targeting systemic lupus erythematosus with nephritis and ANCA-associated vasculitis. Preclinical studies for AZD5658 in lupus are expected to yield results in Q2 2025[8].

Therapeutic areas
Men's HealthOphthalmologyImmunologyEndocrinology
Modalities
Small moleculesOral solid-dosage forms
Industry
Biotech
02

Drug pipeline

4 assets

AZD1656

2

3 more assets in the full pipeline.

Request access →
03

Partnerships

AstraZeneca PLC (license agreement)Charles River Laboratories Inc.Agility Life Sciences (formulation development CDMO)
04

Financials

Market cap
$291.6K
Total revenue
$750.2M
Enterprise value
$970.9M

Beyond the preview

Go deeper on Conduit Pharmaceuticals Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Conduit Pharmaceuticals Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call